Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical Private Limited is a Private Non-govt company company incorporated in 2016 and based in Rajasthan, India. It was founded by Kewal. Kelgan Pharmaceutical Private Limited operates in Medical & Precision (NIC 33309) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2020-21, the company reported revenue of ₹46.94 L and profit after tax of ₹38.4K. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Explore the complete profile of KELGAN PHARMACEUTICAL PRIVATE LIMITED, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Kelgan Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 642230148 | ICICI Bank Ltd(Bank) | ₹13.81 Cr | 19 Sep 2023 | Open |
| 871470564 | HDFC Bank Ltd(Bank) | ₹15.20 Cr | 19 Sep 2019 | Satisfied |
| 562048118 | Axis Bank Ltd(Bank) | ₹13.29 Cr | 12 Mar 2020 | Open |
| 684156210 | ICICI Bank Ltd(Bank) | ₹8.71 Cr | 04 Jul 2020 | Open |
| 180607144 | State Bank of India(Bank) | ₹7.11 Cr | 12 Mar 2022 | Open |
| 154959101 | State Bank of India(Bank) | ₹21.28 Cr | 04 Jul 2020 | Open |
Charge IDs, lenders & amounts for Kelgan Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2020-21 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
3 FYs| Line item | 2020-21 | 2017-18 | 2016-17 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2020-21 | +564.0% | — | — | |
| Profit after Tax2020-21 | +61.0% | — | — | |
| Net Worth2020-21 | +96.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | — | — | -7.56% | -3.64% | 2.08 | |||
| 2017-18 | +2.24% | — | +23.16% | +2.50% | 9.25 | |||
| 2020-21 | +0.82% | +275.73% | +17.80% | +2.61% | 6.83 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,73,96,004 | 58.83% |
| Institutional Investors | 1 | 12,56,738 | 2.70% |
| Public & Others | 17 | 1,79,18,448 | 38.48% |
Promoter, institutional & public holding for Kelgan Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
18 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.